Paspertin en es it fr

Paspertin Brand names, Paspertin Analogs

Paspertin Brand Names Mixture

  • No information avaliable

Paspertin Chemical_Formula


Paspertin RX_link

Paspertin fda sheet

Paspertin FDA

Paspertin msds (material safety sheet)

Paspertin MSDS

Paspertin Synthesis Reference

Thominet, U.S. Pat. 3,177,252 (1965)

Paspertin Molecular Weight

299.796 g/mol

Paspertin Melting Point

147.25 oC

Paspertin H2O Solubility

200 mg/L

Paspertin State


Paspertin LogP


Paspertin Dosage Forms

Liquid; Syrup; Tablet

Paspertin Indication

For the treatment of gastroesophageal reflux disease (GERD)

Paspertin Pharmacology

Metoclopramide, although chemically related to procainamide, does not possess local anesthetic or antiarrhythmic properties. Metoclopramide is used to enhance GI motility, to treat diabetic gastroparesis, as an antinauseant, and to facilitate intubation of the small bowel during radiologic examination. Metoclopramide may be used to treat chemotherapy-induced emesis and as a radiosensitizing agents in the treatment of non-small cell lung carcinoma and glioblastomas in the future.

Paspertin Absorption

Rapidly and well absorbed (oral bioavailability 80±15.5%).

Paspertin side effects and Toxicity

Oral, mouse LD50: 280 mg/kg. Signs of overdose include drowsiness, disorientation, and extrapyramidal reactions.

Paspertin Patient Information

Paspertin Organisms Affected

Humans and other mammals